Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
2,280.50
+29.50 (1.31%)
At close: Mar 6, 2026
3.31% (1Y)
| Market Cap | 515.31B -7.8% |
| Revenue (ttm) | 335.80B +13.6% |
| Net Income | 34.54B +16.8% |
| EPS | 148.61 +14.9% |
| Shares Out | 225.96M |
| PE Ratio | 15.35 |
| Forward PE | 15.52 |
| Dividend | 46.00 (2.04%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 755,100 |
| Average Volume | 949,540 |
| Open | 2,232.00 |
| Previous Close | 2,251.00 |
| Day's Range | 2,218.50 - 2,284.50 |
| 52-Week Range | 1,964.50 - 2,703.00 |
| Beta | -0.55 |
| RSI | 32.59 |
| Earnings Date | Feb 12, 2026 |